DXCM  valuation analysis

Name: DexCom, Inc
Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Apr 29, 2021
Market cap: $39.04B (130th)
Sales(TTM): $2.03B (455th)
Earnings(TTM): $514.00M (245th)

FFER: 2.68 (why)
Actual price: $403.75
FFEThis is DexCom, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $138.01
Quantile: DXCM is very expensive given its fundamentals.
Prices as of EOD 2021-06-16
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
DexCom, Inc
"Diagnostics & Research" industry
Sales / MarketCap
DexCom, Inc
"Diagnostics & Research" industry
Book / MarketCap
DexCom, Inc
"Diagnostics & Research" industry
Equity / Assets
DexCom, Inc
"Diagnostics & Research" industry